|
|
||||||||
From the Departments of Neurology (Drs. Read, Hirano, Abbott, Bladin, and Donnan) and Nuclear Medicine and Centre for Positron Emission Tomography (Drs. Sachinidis, Tochon-Danguy, Chan, Egan, Scott, and McKay), Austin & Repatriation Medical Centre; and the Department of Medicine (Drs. Read and Donnan), University of Melbourne, Australia.
Address correspondence and reprint requests to Dr. Stephen J. Read, Department of Neurology, Austin & Repatriation Medical Centre, Studley Road, Heidelberg, VIC, 3084, Australia.
Objective: To show that PET with 18F-fluoromisonidazole (18F-FMISO) can detect peri-infarct hypoxic tissue in patients after ischemic stroke.
Background: PET with 15O-labeled oxygen and water is the only established method for identifying the ischemic penumbra in humans. We used PET with 18F-FMISO in patients after ischemic stroke to identify hypoxic but viable peri-infarct tissue likely to represent the ischemic penumbra, and to determine how long hypoxic tissues persist after stroke.
Methods: Patients with acute hemispheric ischemic stroke were studied using PET with 18F-FMISO either within 48 hours or 6 to 11 days after stroke onset. The final infarct was defined by CT performed 6 to 11 days after stroke. Tracer uptake was assessed objectively by calculating the mean activity in the contralateral (normal) hemisphere, then identifying pixels with activity greater than 3 SDs above the mean in both hemispheres. Positive studies were those with high-activity pixels ipsilateral to the infarct.
Results: Fifteen patients were studied; 13 within 48 hours of stroke, 8 at 6 to 11 days, and 6 during both time periods. Hypoxic tissue was detected in 9 of the 13 patients studied within 48 hours of stroke, generally distributed in the peripheries of the infarct and adjacent peri-infarct tissues. None of the 8 patients studied 6 to 11 days after stroke exhibited increased 18F-FMISO activity. All 6 patients studied both early and late exhibited areas of increased activity during the early but not the late study.
Conclusions: PET with 18F-FMISO can detect peri-infarct hypoxic tissue after acute ischemic stroke. The distribution of hypoxic tissue suggests that it may represent the ischemic penumbra. Hypoxic tissues do not persist to the subacute phase of stroke (6 to 11 days).
Supported by the National Health and Medical Research Council of Australia (S.J.R., D.F.A.) and by grants from the Sir Edward Dunlop Medical Research Foundation, the Austin Hospital Medical Research Foundation, and the ANZ Trustees.
Received May 5, 1998. Accepted in final form August 14, 1998.
This article has been cited by other articles:
![]() |
M. Takasawa, R. R. Moustafa, and J.-C. Baron Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke Stroke, May 1, 2008; 39(5): 1629 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bruno, T. A. Kent, B. M. Coull, R. R. Shankar, C. Saha, K. J. Becker, B. M. Kissela, and L. S. Williams Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial Stroke, February 1, 2008; 39(2): 384 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Cherk, S. S. Foo, A. M.T. Poon, S. R. Knight, C. Murone, A. T. Papenfuss, J. I. Sachinidis, T. H.C. Saunder, G. J. O'Keefe, and A. M. Scott Lack of Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Non-Small Cell Lung Cancer Assessed by 18F-Fluoromisonidazole and 18F-FDG PET J. Nucl. Med., December 1, 2006; 47(12): 1921 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Spratt, U. Ackerman, H. J. Tochon-Danguy, G. A. Donnan, and D. W. Howells Characterization of Fluoromisonidazole Binding in Stroke Stroke, July 1, 2006; 37(7): 1862 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Cher, C. Murone, N. Lawrentschuk, S. Ramdave, A. Papenfuss, A. Hannah, G. J. O'Keefe, J. I. Sachinidis, S. U. Berlangieri, G. Fabinyi, et al. Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Gliomas Using 18F-Fluoromisonidazole, 18F-FDG PET, and Immunohistochemical Studies J. Nucl. Med., March 1, 2006; 47(3): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Alsop, E. Makovetskaya, S. Kumar, M. Selim, and G. Schlaug Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke Stroke, April 1, 2005; 36(4): 746 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Markus, D. C. Reutens, S. Kazui, S. Read, P. Wright, D. C. Pearce, H. J. Tochon-Danguy, J. I. Sachinidis, and G. A. Donnan Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival Brain, June 1, 2004; 127(6): 1427 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saita, M. Chen, N. J. Spratt, M. J. Porritt, G. T. Liberatore, S. J. Read, C. R. Levi, G. A. Donnan, U. Ackermann, H. J. Tochon-Danguy, et al. Imaging the Ischemic Penumbra with 18F-Fluoromisonidazole in a Rat Model of Ischemic Stroke Stroke, April 1, 2004; 35(4): 975 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Markus, D.C. Reutens, S. Kazui, S. Read, P. Wright, B.R. Chambers, J.I. Sachinidis, H.J. Tochon-Danguy, and G.A. Donnan Topography and Temporal Evolution of Hypoxic Viable Tissue Identified by 18F-Fluoromisonidazole Positron Emission Tomography in Humans After Ischemic Stroke Stroke, November 1, 2003; 34(11): 2646 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-D. Heiss Best Measure of Ischemic Penumbra: Positron Emission Tomography Stroke, October 1, 2003; 34(10): 2534 - 2535. [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association Stroke, April 1, 2003; 34(4): 1056 - 1083. [Full Text] [PDF] |
||||
![]() |
H.-C. Song, H.-S. Bom, K. H. Cho, B. C. Kim, J.-J. Seo, C.-G. Kim, D. J. Yang, and E. E. Kim Prognostication of Recovery in Patients With Acute Ischemic Stroke Through the Use of Brain SPECT With Technetium-99m--Labeled Metronidazole Stroke, April 1, 2003; 34(4): 982 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Schoch, S. Fischer, and H. H. Marti Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain Brain, November 1, 2002; 125(11): 2549 - 2557. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-D. Heiss, L. Kracht, M. Grond, J. Rudolf, B. Bauer, K. Wienhard, and G. Pawlik Early [11C]Flumazenil/H2O Positron Emission Tomography Predicts Irreversible Ischemic Cortical Damage in Stroke Patients Receiving Acute Thrombolytic Therapy Stroke, February 1, 2000; 31(2): 366 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marchal, K. Benali, S. Iglesias, F. Viader, J.-M. Derlon, and J.-C. Baron Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke Brain, December 1, 1999; 122(12): 2387 - 2400. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirano, S. J. Read, D. F. Abbott, J. I. Sachinidis, H. J. Tochon-Danguy, G. F. Egan, C. F. Bladin, A. M. Scott, W. J. McKay, and G. A. Donnan No evidence of hypoxic tissue on 18F-fluoromisonidazole PET after intracerebral hemorrhage Neurology, December 1, 1999; 53(9): 2179 - 2179. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |